NP0332734 | Talaramide A | | | C40H55N7O9
777.9200 Da 777.40613 Da | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|
NP0332735 | Talaramide B | | | C39H53N7O9
763.8930 Da 763.39048 Da | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 700 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|
NP0332736 | Talaramide C | | | C39H53N7O9
763.8930 Da 763.39048 Da | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|
NP0332737 | epicolidine A | | | C26H39NO4
429.6010 Da 429.28791 Da | [1H, 1H] NMR Spectrum (2D, 950 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 950 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 950 MHz, C2D6OS, experimental) |
|
NP0332738 | epicolidine B | | | C26H39NO4
429.6010 Da 429.28791 Da | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCL3, experimental) |
|
NP0332739 | epicolidine C | | | C26H39NO4
429.6010 Da 429.28791 Da | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCL3, experimental) |
|
NP0332740 | 4β,10α-dihydroxy-1α(H)-5α(H)-guai-11(13)-en-8α,12-olide | | | C15H22O4
266.3370 Da 266.15181 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) |
|
NP0332742 | 4β,10α-dihydroxy-1β(H)-5α(H)-guai-11(13)-en-8α,12-olide | | | C15H22O4
266.3370 Da 266.15181 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) |
|
NP0332743 | 1β,4β-dihydroxy-5α(H)-guaia-10(14),11(13)-dien-8α,12-olide | | | C15H20O4
264.3210 Da 264.13616 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) |
|
NP0332747 | 4β,10β-dihydroxy-1β(H)-5α(H)-guai-11(13)-en-8α,12-olide | | | C15H22O4
266.3370 Da 266.15181 Da | 1H NMR Spectrum (1D, 601 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CD3OD, experimental) |
|
NP0332748 | Isoinuviscolide | | | C15H20O3
248.3220 Da 248.14124 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CDCl3, experimental) |
|
NP0332750 | 3α- hydroxycostic acid | | | C15H22O3
250.3380 Da 250.15689 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 601 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 601 MHz, CDCl3, experimental) |
|
NP0332751 | Pseudochelin A | | | C20H23N3O5
385.4200 Da 385.16377 Da | 1H NMR Spectrum (1D, 600 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) |
|
NP0332752 | preussomerin N | | | C40H23NO14
741.6170 Da 741.11185 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 1H NMR Spectrum (1D, 500.15991521, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0332753 | preussomerin O | | | C29H20O11
544.4680 Da 544.10056 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0332754 | 2,3-α-epoxypalmarumycin CP18 | | | C20H12O6
348.3100 Da 348.06339 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0332755 | 3α-hydroxy-CJ-12,372 | | | C20H16O6
352.3420 Da 352.09469 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0332756 | preussomerin K | | | C20H12O8
380.3080 Da 380.05322 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0332757 | preussomerin G | | | C20H10O7
362.2930 Da 362.04265 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0332758 | macommelin-9-ol | | | C9H12O4
184.1910 Da 184.07356 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0332759 | palmarumycin C2 | | | C20H12O5
332.3110 Da 332.06847 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0332760 | palmarumycin C3 | | | C20H12O6
348.3100 Da 348.06339 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0332761 | palmarumycin C11 | | | C20H14O5
334.3270 Da 334.08412 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0332762 | palmarumycin C12 | | | C20H14O6
350.3260 Da 350.07904 Da | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0332763 | palmarumycin BG2 | | | C20H16O5
336.3430 Da 336.09977 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 1H NMR Spectrum (1D, 500, CDCl3, simulated) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|